Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Mechanism of Smoldering Disease

Disease Progression Monitoring

EoETaly Guidelines Part-2

Smoldering Disease Overview

Smoldering Disease Detection

Smoldering Disease Burden

BTK Enzyme

EoETaly Guidelines Part-1

Tolebrutinib Direct Effects on Myeloid Cells in PwMS

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.